-The Times of India MUMBAI: What Indians eat and how could be fueling the diabetes epidemic across the country, suggests a new survey that interviewed 4,000 diabetic patients across eight cities. The main culprit could be the Indian craving for rice, fine-flour rotis or upma - all carbohydrate-based foodstuff high on calories but low on much-needed fibre. "Rice accounts for 48% of the daily calorific intake of most Indians,'' said endocrinologist Dr...

-The Hindu We need to take AIDS out of isolation and look at it in a broader framework, with links to maternal and child health, says Michel Sidibe, Executive Director of UNAIDS. Speaking on the sidelines of the India Africa Forum Summit, Michel Sidibe, Executive Director, UNAIDS, admitted to being ‘scared’ as pressure mounts on India to relax norms, allowing patent protection. In a conversation with Vidya Krishnan, Mr. Sidibe also spoke...

-The Hindu Scientists raise concern over frequent and irresponsible use of antibiotics by animal farm industry Frequent and irresponsible use of antibiotics by the animal farm industry is leading to difficulties in treating common bacterial infections as well as post-surgery infections, a panel of scientists warned at a meeting organised by the Centre for Science and Environment (CSE) on antibiotic resistance, on Tuesday. Dr. Chand Wattal, senior consultant in the Department of Microbiology...

-The Times of India NEW DELHI: New medicines for treatment of diabetes, hypertension and pneumonia are set to be cheaper from Diwali. Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has capped prices of as many as 18 new brands of essential medicines, most of which are expected to be launched in the market within a fortnight. The regulator has brought these medicines under price regulation using paragraph 5 of the Drugs...

-The Times of India LUCKNOW: A scientifically validated anti-diabetes herbal drug, named 'BGR-34', was launched by a Council of Scientific and Industrial Research (CSIR) lab in Lucknow on Sunday. A combination of natural extracts from plants, the drug is based on Ayurveda and has no side effects. The drug is for management of type-II diabetes mellitus. The drug has been jointly developed by two CSIR laboratories, National Botanical Research Institute (NBRI) and...